SCHEMBL2648040

SCHEMBL2648040

CCC/C=C/c1c(C(C)C)nc(C(C)C)c(CO)c1-c1ccccc1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCGR P47871 17/20 0.42
BRD4 O60885 2/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2647364 1.00 GCGR (0.42) GCGRBRD4MCL1
SCHEMBL2648438 0.91 GCGR (0.44) GCGR
SCHEMBL2654624 0.90 GCGR (0.49) GCGR
SCHEMBL2647812 0.87 GCGR (0.45) GCGR
SCHEMBL2647814 0.87 GCGR (0.45) GCGR
SCHEMBL2647952 0.86 GCGR (0.42) GCGRBRD4MCL1
SCHEMBL2647951 0.86 GCGR (0.42) GCGRBRD4MCL1
SCHEMBL2648021 0.85 GCGR (0.47) GCGR
SCHEMBL2648024 0.85 GCGR (0.47) GCGR
SCHEMBL2648266 0.82 GCGR (0.49) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed